Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6204.0000 -11.50 (-0.19%)
NSE May 15, 2025 13:46 PM
Volume: 152.5K
 

logo
Divi's Laboratories Ltd.
25 May 2024
6204.00
-0.19%
buy
by BOB Capital Markets Ltd.
Target: 3000 | Upside : 51.6%
BOB Capital Markets Ltd.
DIVI delivered a strong quarter with all round beat. EBITDA/PAT beat Bloomberg consensus estimate by 20% each
 
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended
Market trades higher, Hitachi Energy's Q4 net profit surges 61.8% YoY to Rs 183.9 crore
Trendlyne Marketwatch | 15 May 2025, 01:42PM
A car running on flat tires: Pakistan's economy is struggling
The Baseline | 15 May 2025, 09:48AM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022